12 January 2015
TapBoost® Technology: Broad Spectrum of Use for Novel Chaperone-driven Platform.
Abstract
Dr. Akinori Hishiya discovered the specific amino acid sequence that enhances protein production and named “BSC1” sequence, the core component of the TAPBOOST® technology platform. This exciting chaperone-driven productivity enhancement exploits the BSC1 sequence to 1) enhance biotherapeutic protein and antibody yields, 2) rescue difficult-to-express protein projects, and 3) efficiently produce research quantities of important disease-relevant proteins.
Dr. Akinori Hishiya, Director of Biology
Paul Wengender, Chief Strategist, TapBoost® Technology
